ArticleJournal of hand surgery global online2025
Clinical Outcomes Following Endoscopic Carpal Tunnel Release With the Arthrex NanoScopic Release System-A Single Surgeon Experience.
Article in Journal of hand surgery global online, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Endoscopic carpal tunnel release (ECTR) is a minimally invasive alternative to open release, offering faster recovery and reduced postoperative discomfort. The Arthrex NanoScopic ECTR system, a novel single-use device using chip-on-tip digital imaging and designed for use under local anesthesia without arthroscopic equipment, may further streamline care and expand surgical access. Methods: A retrospective review was conducted of the first 50 consecutive ECTR procedures performed using the Arthrex NanoScopic system by a single hand fellowship-trained hand surgeon. All procedures were completed under wide-awake local anesthesia no tourniquet technique in an outpatient surgical center. Outcomes included operative times, adverse events, infections, need for reoperation, and anesthesia conversion rates. Patients were followed for a minimum of 3 months after surgery. Results: A total of 50 procedures were performed on 37 patients (13 bilateral), with a median age of 58 years. All cases were completed under local anesthesia without conversion to sedation or general anesthesia. The average operative time was 8 minutes, with the total room time averaging 22 minutes. No reoperations occurred. Four patients (8%) developed postoperative median neuritis, with three cases resolving spontaneously and one attributed to underlying polyneuropathy. One patient presented to the emergency department for pain unrelated to the surgical site, and one patient developed a superficial wound infection resolved with oral antibiotics. Conclusions: The Arthrex NanoScopic ECTR system appears to be a safe, efficient, and minimally invasive option for carpal tunnel syndrome decompression under wide-awake local anesthesia no tourniquet. Its single-use, portable design may reduce the procedural burden and expand access to endoscopic release in office-based or ambulatory settings. Early outcomes demonstrate low complication rates and high procedural success, supporting further evaluation of this technique in broader clinical practice, particularly in an office setting. Type of study/level of evidence: Prognostic II.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.